The treatment landscape for erectile dysfunction has expanded considerably beyond the blue pill. While PDE5 inhibitors remain a first-line option for many men, they are not appropriate for everyone, and they do not address the underlying cause of ED in any case. Effective treatment depends on accurate diagnosis. The right intervention for a man with low testosterone looks very different from the right intervention for a man with performance anxiety or uncontrolled diabetes. This article breaks down the main treatment categories, how they work, and who each one is best suited for.
What ED Treatment Actually Means
Treating ED means two different things depending on the goal. Symptomatic treatment improves erectile function directly, regardless of cause. This is where most men start. Causal treatment addresses the underlying condition driving the dysfunction, which may or may not resolve the ED independently. For lasting improvement, both angles often need to be addressed simultaneously. ( 1 ) A man who takes a PDE5 inhibitor but never addresses his hypertension or low testosterone is managing symptoms without fixing the problem.
How Each Treatment Category Works
PDE5 Inhibitors (Oral Medications)
Phosphodiesterase type 5 inhibitors are the most widely prescribed ED medications. They include sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra). These drugs work by blocking the enzyme that breaks down cyclic GMP, a molecule that promotes smooth muscle relaxation in the penis. By keeping cGMP active longer, PDE5 inhibitors enhance the body’s natural response to sexual stimulation. ( 2 ) They do not create erections in the absence of arousal; they amplify the signal that is already there.
PDE5 inhibitors are effective in approximately 60-70% of men with ED. ( 3 ) They are less effective in men with severe vascular disease, significant nerve damage, or very low testosterone. They are contraindicated in men taking nitrate medications due to the risk of severe hypotension. Side effects include headache, flushing, nasal congestion, and visual disturbances.
Testosterone Replacement Therapy (TRT)
For men whose ED is driven by hypogonadism, testosterone replacement therapy targets the hormonal root cause. TRT restores testosterone to physiological levels, supporting nitric oxide production, smooth muscle integrity, libido, and central arousal pathways. ( 4 ) A 2016 meta-analysis in the Journal of Sexual Medicine found that TRT significantly improved erectile function scores in hypogonadal men, particularly when combined with a PDE5 inhibitor in cases where vascular factors coexisted. ( 5 )
TRT is available in several forms: injectable testosterone (cypionate or enanthate), transdermal gels or patches, subcutaneous pellets, and oral or nasal preparations. Each has different pharmacokinetics, compliance considerations, and side effect profiles. Men considering TRT should review the known side effects and understand that ongoing monitoring is required.
Vacuum Erection Devices (VEDs)
Vacuum erection devices use negative pressure to draw blood into the penis, followed by a constriction ring to maintain the erection. They are non-invasive, drug-free, and effective across a wide range of ED etiologies. ( 6 ) VEDs are particularly useful for men who cannot take PDE5 inhibitors due to cardiovascular contraindications, and for post-prostatectomy rehabilitation. The main drawback is spontaneity: the process requires planning and reduces some degree of natural sensation.
Penile Injections and Intraurethral Suppositories
Intracavernosal injections of vasoactive agents produce erections through direct smooth muscle relaxation, independent of the nitric oxide pathway. This makes them effective in men who do not respond to oral medications. ( 7 ) Alprostadil is the most commonly used agent, available both as an injection and as an intraurethral suppository (MUSE). Response rates are high, but patient acceptance varies due to the administration method. These are typically second-line options after oral medications have failed.
Penile Implants
Inflatable or malleable penile prostheses are surgical devices implanted directly into the corpora cavernosa. They are considered the definitive treatment for men with refractory ED who have not responded to other interventions. ( 8 ) Patient satisfaction rates are among the highest of any ED intervention, exceeding 90% in some studies. They are an appropriate option for men with severe organic ED, particularly those with Peyronie’s disease, post-radical prostatectomy scarring, or end-stage vascular disease.
Psychotherapy and Sex Therapy
For men with predominantly psychological ED, cognitive behavioral therapy and sex therapy address the mental and relational drivers of dysfunction. Performance anxiety, negative cognitive patterns, and relationship conflict are treated through structured therapeutic approaches. ( 9 ) Even in men with organic ED, psychological factors compound the problem, and combined treatment (medication plus therapy) often outperforms either approach alone.
Lifestyle Modification
Multiple studies demonstrate that lifestyle changes alone can produce significant improvements in erectile function. A 2011 review in the Journal of Sexual Medicine found that aerobic exercise, weight loss, and smoking cessation each independently improved ED scores. ( 10 ) For men with mild to moderate ED driven by metabolic risk factors, lifestyle intervention should be a foundational component of treatment, not an afterthought.
Common Myths About ED Treatments
Myth: The pill is always enough. PDE5 inhibitors fail in a substantial proportion of men, particularly those with hormonal, vascular, or neurological causes. If oral medications are not working adequately, further evaluation is warranted.
Myth: TRT is only for bodybuilders. Testosterone therapy is a legitimate, guideline-supported treatment for hypogonadism. Its connection to performance enhancement in athletes has created stigma that discourages men who genuinely need it from pursuing evaluation.
Myth: Implants are a last resort and carry high risk. While implants are typically reserved for refractory cases, modern devices have low complication rates and very high satisfaction scores. They are not experimental or dangerous when performed by experienced surgeons. ( 11 )
When to See a Doctor
Any man with persistent ED should be evaluated before starting treatment, not after trying every over-the-counter option. The evaluation should include a complete medical history, cardiovascular risk assessment, and hormone testing. If you are already on a PDE5 inhibitor but getting suboptimal results, the issue may be an untreated underlying cause. If you have ED alongside symptoms of low testosterone, such as fatigue, weight gain, low mood, or reduced libido, hormone evaluation is essential before or alongside ED-specific treatment.
Find the Right Treatment at Modern Men’s Health
There is no universal ED treatment because there is no universal cause. At Modern Men’s Health, we evaluate the full picture: vascular health, hormone levels, neurological function, and psychological factors. From there, we build a treatment protocol matched to your specific situation. That might mean optimizing testosterone levels, adjusting a medication that is suppressing your function, or combining therapies for maximum effectiveness. If you have been told ED is just “part of getting older” or handed a prescription without any real investigation, we encourage you to dig deeper. The right answer exists; it just requires finding the actual cause first.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Miner MM, Sadovsky R. Evolving issues in male hypogonadism: evaluation, management, and comorbidities. Cleveland Clinic Journal of Medicine. 2007;74(Suppl 3):S38-46. https://doi.org/10.3949/ccjm.74.suppl_3.s38
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. Journal of Urology. 2018;200(3):633-641. https://doi.org/10.1016/j.juro.2018.05.004
- Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Urology. 2010;57(5):804-814. https://doi.org/10.1016/j.eururo.2010.02.020
- Traish AM, Kim N, Min K, et al. Role of androgens in erectile function. Urology. 2003;61(4 Suppl 1):40-48. https://doi.org/10.1016/s0090-4295(03)00059-7
- Corona G, Isidori AM, Buvat J, et al. Testosterone supplementation and sexual function: a meta-analysis study. Journal of Sexual Medicine. 2014;11(6):1577-1592. https://doi.org/10.1111/jsm.12536
- Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urologic Clinics of North America. 2001;28(2):335-341. https://doi.org/10.1016/s0094-0143(05)70143-1
- Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: The management of erectile dysfunction: an AUA update. Journal of Urology. 2005;174(1):230-239. https://doi.org/10.1097/01.ju.0000163062.96021.61
- Montorsi F, Rigatti P, Carmignani G, et al. AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients. European Urology. 2000;37(1):50-55. https://doi.org/10.1159/000020109
- Melnik T, Althof S, Atallah AN, et al. Psychosocial interventions for erectile dysfunction. Cochrane Database of Systematic Reviews. 2007;(3):CD004825. https://doi.org/10.1002/14651858.CD004825.pub2
- Esposito K, Ciotola M, Giugliano F, et al. Effects of intensive lifestyle changes on erectile dysfunction in men. Journal of Sexual Medicine. 2009;6(1):243-250. https://doi.org/10.1111/j.1743-6109.2008.01030.x
- Mulcahy JJ, Austoni E, Barada JH, et al. The penile implant for erectile dysfunction. Journal of Sexual Medicine. 2004;1(1):98-109. https://doi.org/10.1111/j.1743-6109.2004.10115.x